PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of wtpaEurope PMCEurope PMC Funders GroupSubmit a Manuscript
 
J Immunol. Author manuscript; available in PMC Mar 1, 2013.
Published in final edited form as:
PMCID: PMC3427014
UKMSID: UKMS49176
The Bone Marrow Functions as the Central Site of Proliferation for Long-Lived NK Cells
Mary J.G. van Helden,* Natascha de Graaf,* Claire J.P. Boog, David J. Topham, Dietmar M.W. Zaiss,*2 and Alice J.A.M. Sijts*2
*Division of Immunology, Faculty of Veterinary Medicine, University of Utrecht, Yalelaan 1, 3584 CL Utrecht, The Netherlands
Department of Vaccinology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
D. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
Corresponding Authors: Alice Sijts and Dietmar Zaiss ; e.j.a.m.sijts/at/uu.nl; d.zaiss/at/uu.nl Phone: +31 30 2532471 (A. Sijts) or +31 30 2534345 (D. Zaiss) Fax: +31 30 2533555
2Address correspondence and reprint requests to Dr. A. Sijts or Dr. D. Zaiss (shared corresponding authors), Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, University of Utrecht, Yalelaan 1, 3584 CL Utrecht, The Netherlands. e.j.a.m.sijts/at/uu.nl; d.zaiss/at/uu.nl
NK cells play an important role in the early defense against invading pathogens. Although it is well-established that infection leads to a substantial, local increase in NK cell numbers, little is known about the mechanisms that trigger their proliferation and migration. We here investigated the dynamics of NK cell responses following intranasal respiratory virus infection. We show that NK cell numbers increased in the airways following influenza virus infection, but find no evidence of proliferation either at the site of infection or in the draining lymph nodes. Instead, we find that the bone marrow (BM) is the primary site of proliferation of both immature and mature NK cells during infection. Using an adoptive transfer model, we demonstrate that peripheral, long-lived and phenotypically mature NK cells migrate back to the BM and proliferate there, both homeostatically and in response to infection. Thus, the BM is not only a site of NK cell development, but also an important site for proliferation of long-lived mature NK cells.
NK cells are innate lymphocytes that provide early protection against viral infection and tumor growth. Their activation is based on the ratio of activating and inhibitory ligands expressed on the target cell surface that are recognized by NK cell receptors (1). Upon activation, NK cells can kill target cells and produce cytokines that tune the immune response (2). Although viral infections often lead to enhanced NK cell numbers at the site of infection, it is not always clear whether this is the result of increased migration, proliferation, or a combination of the two (3). For example, during infection with murine cytomegalovirus (MCMV), NK cells migrate to the liver (4, 5) and there undergo vigorous proliferation (6). In contrast, in vaccinia virus infected mice, NK cell numbers increase in the peritoneum mainly due to migration while no major proliferation takes place at this site (7). NK cell proliferation does not only lead to increased cell numbers, but can also affect NK cell quality if selective proliferation of certain NK cells subsets takes place, such as during MCMV infection (6). Remarkably, although being part of the innate immune system, recent studies indicate that at least a proportion of NK cells is long-lived (8) and acquires a memory-like phenotype (9-13). Thus, Ly49H+ cells that expand during MCMV infection subsequently gain adaptive traits and are able to respond during recall infection (10). It is currently unknown how these long-lived NK cells are maintained.
NK cells are present both in lymphoid and non-lymphoid organs. In mice, especially the lungs contain high proportions of NK cells (14) and several studies have addressed their role during respiratory virus infections (15-19). For example, the group of Mandelboim (20) showed that influenza virus-encoded hemagglutinin was recognized by the NK cell activating receptor NKp46 leading to killing of influenza virus infected cells. The mechanisms of NK cell migration and/ or proliferation in response to respiratory virus infections however, remain unknown. In this study, we have determined the kinetics of respiratory virus-induced NK cell expansion, contraction and NK cell survival. Surprisingly, we found that not the lung or draining lymphoid tissues but the BM was the primary site of NK cell proliferation during infection. Using an adoptive transfer model, we demonstrated that the BM contained not only immature NK cells but also mature, long - lived NK cells that migrated back from the periphery to undergo both homeostatic and infection-induced proliferation.
Mice, viruses and infection
C57BL/6 (B6) mice were purchased from Charles River. B6.SJL (CD45.1), CD45.1.2 (F1 of B6 × B6.SJL) mice were bred in house under standard conditions. Respiratory syncytial virus (RSV) A2 (a kind gift of A. Easton, University of Warwick, Coventry, UK) was expanded on BSC-1 cells; influenza virus (A/HK/x31; H3N2) on embryonated eggs. Infections were performed using 7-17 weeks old mice that were anesthetized with isofluorane and then infected intranasally (i.n.) with 5 ×106 pfu RSV A2 or 1×105 50% egg infective dose influenza virus HKx31 (21). All animal experiments were approved by the Committee on Animal Experiments (DEC) of the University of Utrecht.
Bromodeoxyuridine (BrdU) incorporation
To measure in vivo proliferation, 0.8 mg/ml BrdU (Sigma Aldrich) was added to the drinking water of naïve and infected mice during the first 6 d of infection. The drinking water was protected from light exposure and changed daily. Mice were sacrificed after 14 d, and organs were harvested. A BrdU pulse was given to uninfected, infected or recipient mice by administration of BrdU i.p. (0.8 mg in 200 ul PBS) and i.n. (0.8 mg in 50 ul PBS), after isofluorane anesthesia. The mice were sacrificed 1 h later and organs were harvested.
Sample collection and tissue preparation
Mice were sacrificed by injection of sodium pentobarbital i.p. and spleens, livers, lungs, BM and BAL were collected for lymphocyte purification. BAL was collected by three times lavage with 1 ml PBS containing 10 μl EDTA and incubated for 1 h at 37°C on a culture dish to remove adherent cells. In some experiments, the first lavage was used for ELISA. BM cells were obtained by flushing the femurs and tibiae. Lungs and liver were perfused with PBS before excision. Lungs were minced and incubated in PBS containing collagenase (2.4 mg/ml; Roche Applied Science) and DNase (1 mg/ml; Roche Applied Science) for 30 min at 37°C. Single-cell suspensions were prepared by passage through cell strainers and lymphocytes were isolated using lympholyte-M (Cederlane) according to manufacturer’s instructions. Differences in frequencies of CD11b and CD27 expressing lung NK cells between DNAse and collagenase treated and untreated samples were smaller than 10% of cells within a specific subset, which is in the range of variation between samples, indicating that this treatment did not lead to a significant loss of CD11b or CD27 expression. Liver lymphocytes were prepared as described (22) with the exception that lympholyte-M (Cederlane) was used for density separation. Single cell suspensions of spleens were prepared by passage through cell strainers. Red blood cells were removed from the spleen and BM by ammonium chloride lysis.
Antibodies and flow cytometry
Cell surface staining with mAbs was performed in the presence of Fc-block (2.4G2), in PBS supplemented with 2% FCS and 0,02% NaN3 for 20-30 min on ice. For intracellular staining of BrdU, cells were fixed with 2% paraformaldehyde for 20 min at room temperature, permeabilized overnight in 0.5% saponine at 4 °C, and then stained for 1 h on ice. Fluorochrome-conjugated antibodies were purchased from eBioscience [CD49b (DX5), CD11b (M1/70), CD27 (LG.7F9), NKp46 (29A1.4), CD45.2 (104), CD45.1 (A20)], Biolegend [TCRβ (H57-597), NK1.1 (PK136)] and Molecular Probes [anti-Brdu (PRB1)]. Samples were measured on a FACSCalibur or FACSCantoII (BD Biosciences) and analyzed with FlowJo software (Treestar).
NK cell isolation, cell labeling and adoptive transfer
NK cells were enriched from peripheral organs (lung, liver, spleen) and BM of naïve mice or mice that had been infected with influenza virus 2-4 weeks earlier, using an NK cell isolation kit (Miltenyi Biotec). For adoptive transfer, 0.3-0.7 × 106 purified cells were injected i.v. into congenic mice. In some experiments, prior to transfer, cells were labeled by incubation with 5 μ M carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen) in PBS, for 10 min at room temperature. CFSE was quenched with fetal calf serum and cells were washed twice with PBS before injection.
Influenza virus infection induces NK cells influx into the airways
To determine the kinetics and phenotype of NK cell responses to respiratory virus infection, we infected B6 mice i.n. with the mouse-adapted influenza virus strain A/HK/x31 (H3N2). Infection induced influx of NK cells into the airways (Fig. 1 A-C). Relative proportions of NK cells peaked between day 3 and 5, and then declined (Fig. 1C), while absolute numbers peaked around day 5 (Fig. 1B). To assess the maturation state of NK cells in different organs of influenza virus infected mice, CD27 and CD11b expression on these cells was measured. NK cells can be divided into distinct subsets, with CD11bCD27 representing the most immature cells, which then progress through the CD11bCD27+ and CD11b+CD27+ stages successively to reach the most mature CD11b+CD27 stage (23, 24). In agreement with earlier reports (23, 24), we found that the BM contained mostly immature CD11bCD27+ and CD11b+CD27+ NK cells and the lungs and spleen mostly mature CD11b+CD27 NK cells (Fig. 1 D). The broncho-alveolar lavage (BAL) contained relatively high percentages of both CD11b+CD27+ and CD11b+CD27 NK cells (Fig. 1 D). From these data we infer that influenza virus infection induced the influx of mostly CD11b+CD27+ and CD11b+CD27 NK cells into the airways.
Figure 1
Figure 1
Influenza virus infection induces influx of NK cells into the airways
The BM is the primary site of NK cell proliferation during respiratory virus infection
To determine whether the influx of NK cells into the airways might be due to enhanced proliferation or enhanced recruitment from other organs, we measured NK cells proliferation in response to respiratory virus infection. We performed a kinetic experiment in which influenza virus-infected and control mice received BrdU i.p. and i.n. for 1 h and then were sacrificed. Strikingly, 3 d post infection (p.i.) hardly any BrdU incorporation was detected in NK cells recovered from the lungs and the BAL, whereas a considerable percentage of NK cells in the BM and a smaller percentage of NK cells in the spleen were BrdU+ (Fig. 2A). Similar results were obtained when measuring expression levels of the proliferation marker Ki-67 (data not shown). The lack of BrdU incorporation in NK cells in the respiratory tissues was unlikely to be due to a lack of recovery of proliferating NK cells or inaccessibility of the cells to BrdU, since T cells in these organs had readily incorporated BrdU in their DNA (data not shown). To examine the maturation status of dividing cells, we measured CD27 and CD11b expression on proliferating cells NK cells in the BM and spleen. NK cells in all maturation stages had incorporated BrdU with the distribution of BrdU+ NK cells resembling the distribution of all NK cells over the different CD11b/CD27 defined subsets (Fig. 2B). Thus, not only immature but also mature NK cells had proliferated.
Figure 2
Figure 2
Respiratory virus infection induces NK cell proliferation in the BM
Taken together, our data indicate that respiratory virus infection induces the proliferation of both mature and immature NK cells, primarily in the BM and to a much smaller extent (Fig. 2A) also in the spleen.
Transferred, long-lived NK cells proliferate homeostatically in the BM
The BM is a well-known place for NK cell development, however, our data so far suggested that also NK cells with a mature phenotype proliferate in the BM. To further determine where mature NK cells proliferate, we transferred NK cells purified from the mouse periphery (lung, liver, spleen) into naïve congenic mice. These NK cells were readily recovered from recipient mice in all organs analyzed (lung, liver, spleen and BM) between the 4-5th week after transfer, indicating that some of these cells were long-lived (Fig. 3 A). While NK cells preferentially homed back to their site of origin (Fig. 3B and data not shown), part of the transferred peripheral NK cells migrated to the BM (Fig. 3 B). A higher proportion of recovered transferred NK cells than endogenous NK cells were CD11b+CD27 in all organs analyzed, indicating that the population of transferred cells was more mature than the population of endogenous NK cells, present in these organs (Fig. 3 C and D).
Figure 3
Figure 3
A proportion of NK cells is long-lived
To assess whether transferred NK cells underwent homeostatic proliferation, we transferred CFSE-labeled peripheral NK cells from the liver, spleen and lungs into congenic recipient mice. Analysis of their CFSE contents 4-5 weeks after transfer showed that only a small percentage of NK cells recovered from the peripheral organs of the acceptor mice, i.e. lung, liver and spleen, had undergone division (Fig. 4 A and B), and of those that had divided, most had undergone not more than one division. In contrast, most of the transferred NK cells recovered from the BM had undergone multiple divisions (Fig. 4 A). To confirm that long-lived NK cells proliferate in the BM and not only preferentially home back there after division, we transferred peripheral NK cells into congenic recipients that received a 1 h BrdU pulse, 3 weeks later. When comparing BrdU incorporation in transferred NK cells in different organs, we exclusively detected BrdU+ NK cells in the BM (Fig. 4 C) indicating that long-lived NK cells proliferate homeostatically in the BM. To further verify that mature peripheral NK cells can migrate to the BM to proliferate there, we adoptively transferred CFSE labeled, FACS-sorted, mature (CD11b+CD27) NK cells into naïve congenic mice. Analysis of CFSE contents of transferred NK cells in the acceptor mice two weeks later showed that the transferred, mature NK cells recovered from the BM had divided significantly more than transferred NK cells recovered from the spleen (Fig. 4 D; for gating strategy, see Supplemental Figure 1). Taken together, these data lead us to infer that mature, adoptively transferred long-lived NK cells undergo homeostatic proliferation in the BM.
Figure 4
Figure 4
Long-lived NK cells proliferate homeostatically in the BM
Respiratory virus infection induces proliferation of long-lived NK cells in the BM
To determine whether long-lived NK cells proliferate in response to respiratory virus infection, we transferred CFSE labeled peripheral NK cells into congenic recipients that were infected with influenza virus 10 days later. Analyses of CFSE profiles of transferred cells 7 days after infection of recipient mice showed a dramatically increased proportion of divided transferred NK cells in the BM of infected compared to uninfected recipients (Fig. 5 A). Infection of recipient mice with RSV caused a similar proliferative response of transferred NK cells in the BM as infection with influenza virus (Fig. 5 B). From these data we infer that a proportion of transferred, mature NK cells migrated to the BM where they were maintained and able to proliferate in response to infection.
Figure 5
Figure 5
Infection-induced proliferation of long-lived NK cells in the BM
Although it is well-established that NK cells play an important role in immune protection to viral infection, relatively little is known about the kinetics of NK cell responses to most viral pathogens. In the current study we investigated the response of NK cells to respiratory viral infections. We found that upon infection, frequencies of NK cells increased in the airways, however, NK cells did not detectably proliferate there. Instead, proliferation occurred preferentially in the BM. We furthermore used an adoptive transfer model to generate mature long-lived NK cells from respiratory virus-infected donor mice and found that a proportion of long-lived NK cells migrated to the BM and there underwent both homeostatic and respiratory virus infection-induced proliferation. Thus, although the BM harbors high amounts of immature, developing NK cells, our data indicate that it is also the central site of proliferation for long-lived NK cells.
Previous studies on interactions between NK cells and influenza virus infected cells by the group of Mandelboim (20) showed that NK cells recognized influenza virus HA through the activating receptor NKp46, which led to target cell killing. Mice that lacked NKp46 died more readily of influenza virus infection than wt mice, despite similar increases in NK cells numbers in the lungs (16). These data suggested that NKp46 ligation leads to activation but not proliferation. Our finding that NK cells barely proliferated in the lungs upon intranasal influenza virus infection further confirms this proposition. In contrast, stimulation of the activating receptor Ly49H through MCMV m157 led to selective proliferation of Ly49H positive NK cells after infection (6). These different outcomes of receptor ligation might have resulted from differences in the signal pathways used by Ly49H and NKp46, which signal through the adaptor protein DAP12 (25) and the FcεRIγ and CD3ζ (26), respectively.
As our results showed that upon influenza virus infection, NK cells proliferated mostly in the BM and not at the site of infection, we conclude that the increased NK cell numbers in the airways (Fig 1B), at least in part, were the result of migration. A similar situation is seen during Listeria monocytogenesis infections. There monocytes proliferate in the BM and emigrate CCR2-dependent into the blood (27). Interestingly, in addition to monocytes, NK cells localized in the BM also express CCR2 (28). Whether NK cells migrate CCR2-dependent from the BM to the site of infection during respiratory virus infection will be the subject of further investigation.
Recent reports have shown that NK cells can mount recall-responses up to several months following sensitization (9, 10, 12, 13). This adaptive trait requires the preservation of antigen-specific NK cells for a long period of time. In the present study, we did not directly address the role of specific cytokines involved in the maintenance of mature NK cells in the BM; however, NK cell homeostatic proliferation has been assessed on NK cells isolated from RAG−/− mice that were adoptively transferred to RAG−/−γc−/− mice backcrossed on an IL-7−/− or IL-15−/− background (29). In addition to having a role in survival of naïve NK cells (30), IL-15 played a dominant role in survival of transferred NK cells (29). Interestingly, when transferred into RAG−/−γc −/−IL-7−/− mice, NK cell proliferation was reduced three-fold (29). Thus, both IL-15 and Il-7 might play an important role in the maintenance of long-lived NK cells.
Our finding that mature NK cells undergo homeostatic proliferation in the BM dovetails well with the maintenance of immunological memory that has extensively been studied for T and B cells and, in the absence of antigen, is believed to depend on survival signals, homeostatic proliferation or a combination of the two (31). The BM is known to play a key role in preservation of immunological memory by being a niche for memory T cells and plasma cells (32-34) and by producing the cytokines needed for survival (33). Memory CD4+ T cells have shown to be in close contact with IL-7 expressing stroma cells, where they are maintained in a low proliferative state and receive IL-7 to survive (33). Memory CD8+ T cells rely both on IL-7 and IL-15 for homeostatic proliferation (30, 35-38). Thus, like other ‘classic’ cells of the adaptive immune system, we here show that a proportion of NK cells behaves in a similar way by migrating back to the BM to undergo homeostatic proliferation
In addition to the cytokines necessary for homeostatic proliferation, a recent studied showed that IL-12 is indispensable for the generation of memory NK cells. Compared to their co-transferred wt counterparts, adoptively transferred IL-12 receptor deficient NK cells could not be recovered 2 weeks after MCMV infection (40). It is currently unknown which cells provide IL-12 for NK cell survival and at what locations.
Taken together, based on our data, we propose that following virus entry and inflammation in the lungs, NK cells migrate from remote storage sites to the site of infection, while the remaining NK cells proliferate at these sites probably to effect their replenishment. After becoming activated, NK cells in the airways produce cytokines and participate in viral clearance. A proportion of NK cells becomes long-lived and can migrate back to the BM where they undergo homeostatic proliferation and rapidly proliferate following re-infection.
Supplementary Material
Acknowledgments
We thank Andrew Easton of the University of Warwick, Coventry, UK, for providing the RSV-A2 strain.
This work was supported by Top Institute Pharma, grant T4-214 and Wellcome Trust Grant WT085733MA.
Abbreviations used in this manuscript
BALbronchoalveolar lavage
RSVrespiratory syncytial virus
MCMVmurine CMV
i.n.intranasal
B6C57BL/6
p.i.post infection

1. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008;9:495–502. [PMC free article] [PubMed]
2. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004;5:1260–1265. [PubMed]
3. Lee SH, Biron CA. Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur. J. Immunol. 2010;40:923–932. [PMC free article] [PubMed]
4. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. Med. 1998;187:1–14. [PMC free article] [PubMed]
5. Salazar-Mather TP, Lewis CA, Biron CA. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Invest. 2002;110:321–330. [PMC free article] [PubMed]
6. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001;2:951–956. [PubMed]
7. Prlic M, Gibbs J, Jameson SC. Characteristics of NK cell migration early after vaccinia infection. J. Immunol. 2005;175:2152–2157. [PubMed]
8. Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 2004;172:864–870. [PubMed]
9. O’Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006;7:507–516. [PubMed]
10. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457:557–561. [PMC free article] [PubMed]
11. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 2009;106:1915–1919. [PubMed]
12. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, von Andrian UH. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 2010;11:1127–1135. [PMC free article] [PubMed]
13. Gillard GO, Bivas-Benita M, Hovav AH, Grandpre LE, Panas MW, Seaman MS, Haynes BF, Letvin NL. Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog. 2011;7:e1002141. [PMC free article] [PubMed]
14. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunol. Rev. 2007;220:169–182. [PubMed]
15. Stein-Streilein J, Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 1986;136:1435–1441. [PubMed]
16. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006;7:517–523. [PubMed]
17. Hussell T, Openshaw PJ. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 1998;79(Pt 11):2593–2601. [PubMed]
18. Hussell T, Openshaw PJ. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J. Immunol. 2000;165:7109–7115. [PubMed]
19. Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS. NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J. Immunol. 2010;185:4681–4690. [PubMed]
20. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409:1055–1060. [PubMed]
21. Polakos NK, Klein I, Richter MV, Zaiss DM, Giannandrea M, Crispe IN, Topham DJ. Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses. J. Immunol. 2007;179:201–210. [PubMed]
22. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, Budd RC. Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J. Exp. Med. 1998;188:1147–1157. [PMC free article] [PubMed]
23. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006;176:1517–1524. [PubMed]
24. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009;113:5488–5496. [PubMed]
25. Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 1998;161:7–10. [PubMed]
26. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998;187:2065–2072. [PMC free article] [PubMed]
27. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006;7:311–317. [PubMed]
28. Shi C, Velazquez P, Hohl TM, Leiner I, Dustin ML, Pamer EG. Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J. Immunol. 2010;184:6266–6274. [PMC free article] [PubMed]
29. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Muller W, Di Santo JP. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood. 2003;101:4887–4893. [PubMed]
30. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000;191:771–780. [PMC free article] [PubMed]
31. Gourley TS, Wherry EJ, Masopust D, Ahmed R. Generation and maintenance of immunological memory. Semin. Immunol. 2004;16:323–333. [PubMed]
32. Mazo IB, Honczarenko M, Leung H, Cavanagh LL, Bonasio R, Weninger W, Engelke K, Xia L, McEver RP, Koni PA, Silberstein LE, von Andrian UH. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity. 2005;22:259–270. [PubMed]
33. Tokoyoda K, Zehentmeier S, Hegazy AN, Albrecht I, Grun JR, Lohning M, Radbruch A. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity. 2009;30:721–730. [PubMed]
34. Benner R, Meima F, van der Meulen GM, van Muiswinkel WB. Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ. Immunology. 1974;26:247–255. [PubMed]
35. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 2002;195:1523–1532. [PMC free article] [PubMed]
36. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000;1:426–432. [PubMed]
37. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9:669–676. [PubMed]
38. Wherry EJ, Becker TC, Boone D, Kaja MK, Ma A, Ahmed R. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha. Adv. Exp. Med. Biol. 2002;512:165–175. [PubMed]
39. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 2002;168:4827–4831. [PubMed]
40. Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier LL. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 2012;209:947–954. [PMC free article] [PubMed]